Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors

Published:2022-06-17 Issue:9 Volume:27 Page:1413-1420
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Aoki Yu,Kawazoe Akihito,Kubota Yohei,Chida Keigo,Mishima Saori,Kotani Daisuke,Nakamura Yoshiaki,Kuboki Yasutoshi,Bando Hideaki,Kojima Takashi,Doi Toshihiko,Yoshino Takayuki,Kuwata Takeshi,Shitara Kohei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-022-02200-1.pdf

Reference18 articles.

1. Han JJ, Kim JW, Suh KJ et al (2019) Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer. Asia Pac J Clin Oncol 15:158–165. https://doi.org/10.1111/ajco.13145

2. Unger JM, Barlow WE, Martin DP, et al (2014) Comparison of survival outcomes among cancer patients treated in and out of clinical trials. Jnci J National Cancer Inst 106:dju002. https://doi.org/10.1093/jnci/dju002

3. Go RS, Frisby KA, Lee JA et al (2006) Clinical trial accrual among new cancer patients at a community-based cancer center. Cancer 106:426–433. https://doi.org/10.1002/cncr.21597

4. Elting LS, Cooksley C, Bekele BN et al (2006) Generalizability of cancer clinical trial results. Cancer 106:2452–2458. https://doi.org/10.1002/cncr.21907

5. Ohno S, Mukai H, Narui K et al (2019) Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study. Breast Cancer Res Treat 176:631–635. https://doi.org/10.1007/s10549-019-05276-y

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study;International Journal of Clinical Oncology;2024-04-28

2. Chronological improvement of survival in patients with advanced gastric cancer over 15 years;Therapeutic Advances in Medical Oncology;2024-01